Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02263196
Other study ID # 921839
Secondary ID
Status Recruiting
Phase Phase 1/Phase 2
First received September 26, 2014
Last updated April 7, 2015
Start date September 2014
Est. completion date May 2015

Study information

Verified date April 2015
Source Mashhad University of Medical Sciences
Contact ali bazzi, MSc student
Phone 09113723582
Email bazzia911@mums.ac.ir
Is FDA regulated No
Health authority Iran: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study was to compare the efficacy of combination of alcohol and povidone iodine 10% and Alcohol 70% after povidone iodine 10% on inflammation and infection related to vascular access area in hemodialysis patients.


Description:

These cases were identified from patient that lack of specific diseases; Non-use of antibiotics or immunosuppressive drugs. That the participants will be selected using convenience sampling method and randomly divided into three groups: combination of alcohol and povidone iodine 10%, Alcohol after and control groups. In the Intervention in one group the vascular access site disinfected with Alcohol(group1) and in group 2, Alcohol and povidone iodine 10% was used to separate were disinfected. Then the patient in a month of inflammation and infection of the vascular access will be monitor. Exclusion criteria: inflammation or fistula failure during the study for any reason other than infection. Sample size determination: Through the pilot study. Date: 02.10.2014 till 02.11.2014 Outcome: Washing with both solution affected on reduce the inflammation and infection of the patient.

the efficacy of Alcohol after Betadine and combination of alcohol and Betadine on inflammation and infection related to Vascular access hemodialysis patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 96
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- absence of inflammatory vascular access site

- three dialysis sessions per week

Exclusion Criteria:

- patient dies

- patient withdrew from the partnership

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Alcohol and povidone iodine
using from Alcohol and povidone iodine for prevention of inflammation
combination of alcohol and betadin
using from combination Alcohol and povidone iodine for prevention of inflammation

Locations

Country Name City State
Iran, Islamic Republic of Ali Bazzi Mashhad

Sponsors (1)

Lead Sponsor Collaborator
Mashhad University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

References & Publications (1)

Brañas P, Morales E, Ríos F, Sanz F, Gutiérrez E, Quintanilla N, Orellana MA, Sánchez M, Rodríguez-Aranda A, Chaves F. Usefulness of endoluminal catheter colonization surveillance cultures to reduce catheter-related bloodstream infections in hemodialysis. Am J Infect Control. 2014 Nov;42(11):1182-7. doi: 10.1016/j.ajic.2014.07.022. Epub 2014 Sep 22. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary effected of betadin and alcohol on inflammation and infection of the patient up to one month Yes
See also
  Status Clinical Trial Phase
Completed NCT01396980 - Microcirculation During Haemodialysis N/A
Completed NCT02513303 - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Phase 3
Completed NCT02443376 - The Effects of Hemodialysis Session on Vascular Stiffness N/A
Completed NCT01825590 - Effects of Simple Sodium Alignment on Clinical Outcomes N/A
Completed NCT02558153 - RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula N/A
Completed NCT00322322 - Early Administration of L-carnitine in Hemodialysis Patients Phase 3
Completed NCT02870829 - Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K Phase 2
Completed NCT00501956 - Intradialytic Parenteral Nutrition in Hemodialysis Patients Phase 4
Completed NCT02950389 - REmoval of Free Light Chains. A COmpaRison of Three Different dialyzERs N/A
Recruiting NCT02446535 - Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW? N/A
Completed NCT00568399 - Sodium Thiosulfate Treatment of Vascular Calcification in ESRD N/A
Recruiting NCT05425056 - A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery Phase 3
Completed NCT01278693 - Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients Phase 2
Completed NCT00732069 - Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis Phase 2
Completed NCT02747966 - The Relationship Between the Flow of Arteriovenous Fistula and Cardiac Function in Haemodialysis Patients N/A
Completed NCT01147354 - Effect of Selenium Supplementation on Inflammatory,Oxidative and Nutritional Markers in Hemodialysis Patients Phase 3

External Links